Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2021-12-14 00:00:00 ET · period of report 2021-12-10 · accession 0001735276-21-000091 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-14 | 2021-12-10 | ALNY | MARAGANORE JOHN | CEO, Dir | M - OptEx | $74.50 | +5,367 | 220.1K | +2% | +$399.8K |
| DM | 2021-12-14 | 2021-12-10 | ALNY | MARAGANORE JOHN | CEO, Dir | M - OptEx | $0.00 | -5,367 | 74.0K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-10 | M | A | 839 | $119.13 | 217,764 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-10 | M | A | 1,124 | $88.95 | 216,925 | D | — | — | |
| 3 | Common | Common Stock | 2021-12-10 | M | A | 1,036 | $96.45 | 215,801 | D | — | — | |
| 4 | Common | Common Stock | 2021-12-10 | M | A | 2,368 | $42.22 | 220,132 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2021-12-10 | M | D | 2,368 | $0.00 | 22,632 | D | $42.22 · — to 2026-12-20 | 2,368 Common Stock | (F2) The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. |
| 6 | Derivative | Stock Option (right to buy) | 2021-12-10 | M | D | 839 | $0.00 | 51,661 | D | $119.13 · — to 2028-02-28 | 839 Common Stock | (F3) The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to the remaining shares ratably at the end of each three-month period thereafter over the following thirty-three (33) months. |
| 7 | Derivative | Stock Option (right to buy) | 2021-12-10 | M | D | 1,124 | $0.00 | 63,876 | D | $88.95 · — to 2025-12-18 | 1,124 Common Stock | (F2) The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. |
| 8 | Derivative | Stock Option (right to buy) | 2021-12-10 | M | D | 1,036 | $0.00 | 73,964 | D | $96.45 · — to 2024-12-17 | 1,036 Common Stock | (F2) The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. |